Purchase Order 75N92023P00227
- Not listed
- The National Institutes of Health National Heart, Lung and Blood Institute awarded a firm fixed price purchase order valued at $21,000 to Repeat Diagnostics Inc. of Ottawa, Canada. Under this contract, Repeat Diagnostics will provide telomere length measurement services using flow fluorescence in situ hybridization (flow-FISH) assay for samples from the Young Lab Members at NIH NHLBI. The work will involve testing patient samples from the lab's clinic to repeat their telomere length...
- Repeat Diagnostics Inc. has been awarded a firm fixed price purchase order from the National Institutes of Health's National Heart, Lung and Blood Institute (NIH NHLBI) for $31,250. The contract is for specialized flow fluorescence in situ hybridization (flow-FISH) telomere length measurement services to support NHLBI research protocols and patient care through March 2025. Repeat Diagnostics will provide its Flow-FISH 2-Panel assay to measure telomere length using clinical samples, advancing the...
- The National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), awarded a $16,750.00 firm fixed-price purchase order contract to Repeat Diagnostics Inc., a specialized laboratory services provider based in Ottawa, Canada. The contract is for the provision of 2-panel assays to measure telomere length using flow fluorescence in situ hybridization (flow-FISH) technology. These services support NHLBI's biomedical research efforts, enabling clinicians to...
- This is a $10,050.00 firm fixed-price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH), to Repeat Diagnostics Inc., a specialized laboratory services provider based in Canada. The contract is for the provision of a 2-panel assay to measure telomere length using flow fluorescence in situ hybridization (flow-FISH) technology, which is a valuable diagnostic tool for NHLBI's research on disease...
- <p>The National Heart Lung and Blood Institute awarded a purchase order to Repeat Diagnostics Inc. for $34,800 on December 5, 2017 for flow-FISH 2-panel telomere length measurements, with completion due December 10, 2018. Performance occurs at 2323 Riverside Drive, Ottawa, Ontario, Canada. The order is firm fixed price with no set-aside applied.</p>
- <p>The National Heart, Lung and Blood Institute awarded a purchase order to Repeat Diagnostics Inc. for $24,000 on December 11, 2019. The order, which carries no set-aside designation, calls for 2-panel assay telomere length measurement by flow-FISH on patient samples from the National Heart, Lung and Blood Institute's clinic. Work is performed in Bethesda, Maryland. The purchase order is firm fixed price with an ultimate completion date of January 10, 2020.</p>
- <p>The National Heart Lung and Blood Institute awarded a purchase order to Repeat Diagnostics Inc. for $34,800 on March 14, 2017. The order covers 2-panel flow-FISH testing services with an ultimate completion date of March 13, 2018. Performance occurs in Bethesda, Maryland. The pricing is firm fixed price with no small business set-aside.</p>
- <p>The NIH Clinical Center issued a delivery order to Repeat Diagnostics Inc. on April 19, 2018, with a ceiling value of $6,000 for laboratory testing services of telomere length assays supporting the Inherited Bone Marrow Failure Study.</p> <p>Work is performed at 2323 Riverside Drive, Ottawa, Ontario, Canada. The order is firm fixed price with an ultimate completion date of April 22, 2019. No set-aside was used.</p>
- <p>The National Cancer Institute issued a delivery order to Repeat Diagnostics Inc. on December 18, 2015, with a ceiling value of $4,450.00 for laboratory testing services of telomere length assays supporting the Inherited Bone Marrow Failure Study.</p> <p>Place of performance is Rockville, Maryland. The order was firm fixed price with an ultimate completion date of May 26, 2021. The award involved de-obligation of funds from expiring FY2016 lines and was issued under no set-aside.</p>
- <p>The National Cancer Institute issued a purchase order to Repeat Diagnostics Inc. for $25,000 on September 14, 2018, to provide lab testing and services for a 6-panel flow FISH assay. Performance occurs at the vendor's facility in Ottawa, Ontario, Canada. The order is firm fixed price with a completion date of September 13, 2019.</p>
The National Institutes of Health National Heart Lung and Blood Institute awarded a $11,250 firm fixed price purchase order to Repeat Diagnostics Inc. to provide telomere flow fluorescence in situ hybridization testing for 45 clinical samples in support of Protocol 17-H-0121. The testing is required to continue patient care, evaluate efficacy and disease progression during the course of drug therapy under the protocol. Repeat Diagnostics will perform the testing at its laboratory located in Ottawa, Ontario, Canada between July 7 and July 28, 2023. No set aside designation or subcontractors were identified. The award provides specialized diagnostic services to the NIH NHLBI to advance its biomedical research mission in cardiopulmonary medicine.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.3k | 7/7/23 |